<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" generatedBy="WIX">
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/intraluminal-bile-duct-high-dose-rate-brachytherapy-for-malignant-biliary-tract-obstruction</loc>
<lastmod>2025-02-19</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/a-study-of-a-selective-t-cell-receptor-(tcr)-targeting%2C-bifunctional-antibody-fusion-molecule-star0602-in-participants-with-advanced-solid-tumors</loc>
<lastmod>2023-12-14</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/study-of-dato-dxd-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-patients-with-advanced-solid-tumours</loc>
<lastmod>2023-12-14</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/first-in-human-study-to-evaluate-azd8205-in-patients-with-advanced-or-metastatic-solid-malignancies</loc>
<lastmod>2023-12-14</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/amg-193%2C-methylthioadenosine-(mta)-cooperative-protein-arginine-methyltransferase-5-(prmt5)-inhibitor%2C-alone-and-in-combination-with-docetaxel-in-advanced-methylthioadenosine-phosphorylase-(mtap)-null-solid-tumors</loc>
<lastmod>2023-12-14</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/study-of-ly3537982-in-cancer-patients-with-a-specific-genetic-mutation-(kras-g12c)</loc>
<lastmod>2023-12-14</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/study-of-azd5305-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-patients-with-advanced-solid-malignancies</loc>
<lastmod>2023-12-14</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/a-study-of-rilvegostomig-plus-chemotherapy-as-adjuvant-therapy-for-biliary-tract-cancer-after-resection-</loc>
<lastmod>2024-03-06</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/a-study-to-evaluate-the-efficacy-and-safety-of-pemigatinib-versus-chemotherapy-in-unresectable-or-metastatic-cholangiocarcinoma</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/molecular-profiling-of-advanced-biliary-tract-cancers</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/durvalumab-and-tremelimumab-in-combination-with-propranolol-and-chemotherapy-for-treatment-of-advanced-hepatopancreabiliary-tumors-(blocked)</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/study-of-pembrolizumab-(mk-3475)-in-participants-with-advanced-solid-tumors-(mk-3475-158%2Fkeynote-158)</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/mk-7684a-with-or-without-other-anticancer-therapies-in-participants-with-selected-solid-tumors-(mk-7684a-005)-(keyvibe-005)</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/a-study-evaluating-bemarituzumab-in-solid-tumors-with-fibroblast-growth-factor-receptor-2b-(fgfr2b)-overexpression</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/a-study-of-sgn-b7h4v-in-advanced-solid-tumors</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/liver-transplantation-for-early-intrahepatic-cholangiocarcinoma</loc>
<lastmod>2023-12-11</lastmod>
</url>
<url>
<loc>https://www.cholangio.ca/fr/clinicaltrials/quebec-pancreas-cancer-study</loc>
<lastmod>2023-12-11</lastmod>
</url>
</urlset>